Further analysis of the data using a 50% cut-off showed that high levels of MIF in metastatic disease conferred significantly poorer outcome compared to those tumours expressing lower levels of MIF mRNA (univariate Cox regression; hazard ratio = 2.946; 95% confidence interval 1.440-6.029; p = 0.003; Figure 7C). This evidence concerns the gene MIF and neoplasm.